Uddrivningsfraktionen øgedes signifikant, og LVIDD reduceredes signifikant fra baseline til endepunkt hos patienter behandlet med valsartan sammenlignet med placebo.
Ejection fraction in valsartan treated patients was significantly increased and LVIDD significantly reduced from baseline at endpoint compared to placebo.